Short answer · Medically reviewed summary · Last updated: 2026-04-07
Peyronie's disease is primarily caused by abnormal wound healing of the tunica albuginea, the fibrous sheath surrounding the erectile tissue of the penis, often following minor or repetitive trauma. While the exact trigger for this excessive scarring remains under investigation, it is believed to result from a complex interplay between genetic predisposition, chronic micro-trauma, and systemic inflammatory processes. What exactly causes Peyronie's disease to develop? At its core, Peyronie's disease is a disorder of connective tissue remodeling.
Peyronie's disease is primarily caused by abnormal wound healing of the tunica albuginea, the fibrous sheath surrounding the erectile tissue of the penis, often following minor or repetitive trauma. While the exact trigger for this excessive scarring remains under investigation, it is believed to result from a complex interplay between genetic predisposition, chronic micro-trauma, and systemic inflammatory processes.
At its core, Peyronie's disease is a disorder of connective tissue remodeling. Think of the tunica albuginea as a flexible, rubber-like sleeve. In an individual with Peyronie's disease, the body’s natural repair mechanism after a micro-injury—such as a minor bend during intercourse—goes into overdrive. Instead of healing with elastic, healthy tissue, the body deposits excess collagen and fibrin, creating a rigid, inelastic plaque. This plaque acts like a patch on a balloon; when the penis expands during an erection, the patch prevents that specific area from stretching, causing the characteristic curvature, pain, and deformity associated with the condition.
While Peyronie's disease is not considered a classic genetic disease caused by a single mutation, research suggests a strong hereditary component. Many patients with Peyronie's disease also exhibit traits associated with Dupuytren’s contracture, a condition involving thickening of the tissue in the palm of the hand. Both conditions share a genetic predisposition toward abnormal fibroproliferative responses, meaning the body is "programmed" to over-produce scar tissue in response to minor insults.
It is important to distinguish between the cause (the underlying biological scar-forming process) and risk factors (conditions that increase the likelihood of the process triggering). Clinical data indicates several key factors:
The etiology of Peyronie's disease is not yet fully understood, and it remains a very active area of medical research. Scientists are currently focused on the "TGF-beta" pathway—a signaling protein that regulates cell growth and wound healing. In patients with Peyronie's disease, this pathway seems to be dysregulated, leading to persistent inflammation rather than the resolution of a wound. Current research is examining whether pharmacological interventions can modulate this pathway to prevent plaque formation or potentially soften existing plaques.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.